Nivolumab 240mg/20ml / Relatlimab 80mg/20ml solution for infusion vials

in short Nivolumab 240mg/20ml / Relatlimab 80mg/20ml inf vials

SNOMED code
42683911000001101
Active compound
Nivolumab + Relatlimab
Preferred name basis
Other
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
20 ml, vial
Ingredients
Relatlimab — 4 mg / 1 ml based on ingredient substance
Nivolumab — 12 mg / 1 ml based on ingredient substance
Form & Route
solutioninfusion.intravenous
Solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Opdualag 240mg/20ml / 80mg/20ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd)

in short Opdualag 240mg/20ml / 80mg/20ml concentrate for inf vials

Opdualag 240mg/20ml / 80mg/20ml concentrate for solution for infusion vials

SNOMED code
42675811000001102
Supplier
Bristol-Myers Squibb Pharmaceuticals Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Opdualag 240mg/20ml / 80mg/20ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial
42675911000001107   ref. pack
💯 Available

Legal category: POM
05012712800071
NHS Indicative Price
£6,134
• Hospital
  • • Prescription Charges

Reference packs

Nivolumab 240mg/20ml / Relatlimab 80mg/20ml solution for infusion vials 1 vial
SNOMED code
42675711000001105
Quantity and unit
1 vial
Packs